NCT06145542Completed
Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D
Sequences of Aerobic and Resistance Exercise in Training and Their Effects on Cardio-metabolic Functions Among Type 2 Diabetes Patients - a Randomized Study
Source: ClinicalTrials.gov · Last updated 3 Apr 2025
Brief summary (registry, in English)
Aerobic exercise and resistance exercise are two types of exercise commonly used in physical conditioning. Compared to aerobic exercise, a combination of aerobic and resistance exercise has been linked to a greater reduction in hemoglobin A1c (HbA1c) among patients with type 2 diabetes (T2D). However, it is not clear that in a concurrent aerobic-resistance training session, whether the orders of the two types of exercise could act differently in glucose metabolism. This randomized trial aims to investigate the effect of the sequence of exercise modalities (aerobic-resistance vs resistance-aerobic in a training session) on glycemic control among T2D patients following an 8-wk intervention period.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 56 (actual)
- First submitted
- 17 Nov 2023
- Start date
- 25 Sept 2023
- Primary completion date
- 2 Feb 2024
- Lead sponsor
- Zhejiang University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06145542
What you commit to
- Study type: Interventional
- Participants enrolled: 56
- From 25 Sept 2023 to the primary completion date, 2 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Type 1 diabetes;
- Severe complications of diabetes such as acute infection, diabetic ketoacidosis, and plantar lesions;
- Severe kidney disease, cardiovascular and cerebrovascular diseases as identified by a specialist;
- Musculoskeletal, neurological, psychiatric or other disorders which limit the ability to exercise as identified by a specialist;
- Other comorbidities or medications irrelevant to diabetes treatment that may influence glycemia during the past 6 months
Lab values
- Fasting blood glucose (FBG)\>16.7mmol/L;
Other
- Doing physical exercise regularly (≥ 3 times per week, at least 1 hour per session of moderate to vigorous activities);
- Currently under dietary program for weight loss;
- Systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥100 mmHg at rest;
- Abnormal electrocardiogram (rest and exercise);
Who the study is looking for
- Age 50-70 years;
- Type 2 diabetes diagnosed as: random blood glucose ≥11.1mmol/L (200mg/dL) or fasting blood glucose ≥7.0mmol/L (126mg/L) or oral glucose tolerance test (2h) ≥11.1mmol/L (200mg/dL) or glycated hemoglobin (HbA1c) ≥ 6.5%;
- The course of type 2 diabetes lasted for one year or longer;
- Willing to participate and sign the informed consent form voluntarily
Age in the registry: 50 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maigaoqiao Community Health Service Center Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.